[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Target PharmaSolutions, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":102},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,44,65,85],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100650478","an-observational-study-of-patients-with-dermatologic-disease-100650478",false,"NCT07748169","An Observational Study of Patients With Dermatologic Disease","TARGET-DERM+","Inclusion Criteria:\n\n* Adult or pediatric participants managed for DD invited to participate OR a provider who treats patients with these conditions. Informed consent is required for all Engaged Cohort participants.\n* Adult or pediatric participants at the time of enrollment with a diagnosis of DD by ICD code or other relevant healthcare code as part of the EHR interface.\n\nExclusion Criteria:\n\n* Participant withdrew consent; Failure to complete activities as required per the cohort clarification letter.","ALL",{"count":18,"type":19},2000000,"ESTIMATED","15 Years","OBSERVATIONAL","TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and\u002For data from providers who treat them.",[24,25,26,27],"Vitiligo","Atopic Dermatitis","Alopecia Areata","Hidradenitis Suppurativa (HS)",[29,30],"Dermatologic Disease","DERM+","RECRUITING","2026-07-31",{"date":34,"type":35},"2026-08-05","ACTUAL",{"date":37,"type":19},"2026-08-01",{"date":39,"type":19},"2041-08-03",{"name":41,"class":42},"Target PharmaSolutions, Inc.","INDUSTRY",3,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":56,"whyStopped":4,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":4},"100504019","an-observational-study-of-patients-with-autoimmune-disease-100504019","NCT05842824","An Observational Study of Patients With Autoimmune Disease","Disease Cohort\n\nInclusion Criteria:\n\n\\- Adult patients at the time of enrollment with a diagnosis autoimmune disease by select ICD-10 codes in the EHR interface\n\nExclusion Criteria:\n\n* Death\n* Manual removal (sponsor or site request)\n* No EHR interface encounter \\> 3 years\n\nEngaged Cohort\n\nInclusion Criteria:\n\n* Adult patients diagnosed and managed for these conditions invited to participate\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Patient expressed desire to withdraw consent to complete PROs\n* Failure to complete PROs within 24 weeks of initial invitation\n* Greater than 24 months lapse of survey completion after baseline surveys completed\n* Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort","18 Years",{"count":52,"type":19},500000,"TARGET-AUTOIMMUNE is an observational research study to conduct a comprehensive review of outcomes for patients with autoimmune and related diseases. .",[55],"Autoimmune Diseases","NOT_YET_RECRUITING","2024-11-18",{"date":59,"type":35},"2024-11-20",{"date":61,"type":19},"2025-03-31",{"date":63,"type":19},"2038-12-31",{"name":41,"class":42},{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":69,"acronym":4,"eligibilityCriteria":70,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":4,"enrollmentInfo":71,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":73,"conditions":74,"keywords":4,"overallStatus":56,"whyStopped":4,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":81,"startDateStruct":82,"completionDateStruct":83,"leadSponsor":84,"locationsCount":4},"100500421","an-observational-study-of-patients-living-with-chronic-neurological-diseases-100500421","NCT05796037","An Observational Study of Patients Living With Chronic Neurological Diseases","Disease Cohort\n\nInclusion Criteria:\n\n•Adult patients at the time of enrollment with a diagnosis of ADRD, MCI, PD, or MS by select ICD-10 codes in the EHR interface\n\nExclusion Criteria:\n\n* Death\n* Manual removal (sponsor or site request)\n* No EHR interface encounter \\> 3 years\n\nEngaged Cohort\n\nInclusion Criteria:\n\n* Adult patients diagnosed and managed for these conditions invited to participate\n* Ability to provide written informed consent (or have a legally authorized representative to provide informed consent)\n* Care partners may be invited to participate in surveys and will provide informed consent.\n\nExclusion Criteria:\n\n* Patient expressed desire to withdraw consent to complete PROs\n* Care partner expressed desire to withdraw consent to complete PROs\n* Failure to complete PROs within 24 weeks of initial invitation\n* Greater than 24 months lapse of survey completion after baseline surveys completed\n* Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort\n\nAge Cohort\n\nInclusion Criteria:\n\n•Adult patients aged 60 and older at time of enrollment\n\nExclusion Criteria:\n\n* Death\n* Manual removal (sponsor or site request)\n* No EHR interface encounter \\> 3 years",{"count":72,"type":19},1500000,"TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).",[75,76,77,78,79,80],"Neurological Diseases or Conditions","Dementia of Alzheimer Type","Alzheimer Disease","Mild Cognitive Impairment","Parkinson Disease","Multiple Sclerosis",{"date":59,"type":35},{"date":61,"type":19},{"date":63,"type":19},{"name":41,"class":42},{"id":86,"slug":87,"hasResults":11,"nctId":88,"briefTitle":89,"officialTitle":89,"acronym":4,"eligibilityCriteria":90,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":4,"enrollmentInfo":91,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":92,"conditions":93,"keywords":4,"overallStatus":56,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":101,"locationsCount":4},"100504018","an-observational-study-of-patients-with-metabolic-syndrome-and-related-conditions-100504018","NCT05842811","An Observational Study of Patients With Metabolic Syndrome and Related Conditions","Disease Cohort\n\nInclusion Criteria:\n\n\\- Adult patients at the time of enrollment with a diagnosis of metabolic syndrome or related conditions by ICD-10 code or with clinically calculated BMI ≥ 30 in the EHR\u002Fhealth system interface\n\nExclusion Criteria:\n\n* Death\n* Manual removal (sponsor or site request)\n* No EHR interface encounter \\> 3 years\n\nEngaged Cohort\n\nInclusion Criteria:\n\n* Adult patients diagnosed and managed for these conditions invited to participate\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Patient expressed desire to withdraw consent to complete PROs\n* Failure to complete PROs within 24 weeks of initial invitation\n* Greater than 24 months lapse of survey completion after baseline surveys completed\n* Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort",{"count":18,"type":19},"TARGET-METABOLIC is an observational research study to conduct a comprehensive review of outcomes for patients with metabolic syndrome and related conditions.",[94],"Metabolic Syndrome","2023-04-24",{"date":97,"type":35},"2023-05-06",{"date":99,"type":19},"2023-05-24",{"date":63,"type":19},{"name":41,"class":42},""]